1.ÕªÒª
2022Äê2ÔÂ9ÈÕ£¬1xbetÍøÒ³°æ¹ùÓÀÍŶÓÓë±±¾©´óѧµÚÒ»Ò½Ôº¡¢Ê×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©¸¾²úÒ½ÔººÏ×÷£¬ÔÚ¹ú¼ÊÖøÃûѧÊõÆÚ¿¯¡¶·ÖÎö»¯Ñ§¡·£¨Analytical Chemistry£©·¢±íÁËÌâΪ¡°ÓÃÓÚ¼¹ËèÐÔ¼¡ÈâήËõÖ¢·Ö×ÓÕï¶ÏºÍ¼²²¡ÑÏÖØ³Ì¶ÈÆÀ¹ÀµÄµ¥¹Ü¶àÖØÊý×Ö¾ÛºÏøÁ´Ê½·´Ó¦¼ì²â·½·¨¡±£¨Single-Tube Multiplex Digital Polymerase Chain Reaction Assay for Molecular Diagnosis and Prediction of Severity of Spinal Muscular Atrophy£©µÄÎÄÕ£¬²¢±»Ñ¡ÎªÔÓÖ¾·âÃæ¡£¼¹ËèÐÔ¼¡Î®ËõÖ¢£¨Spinal muscular atrophy£¬SMA£©ÊǶùͯ×î³£¼ûµÄÒÅ´«ÐÔÉñ¾¼¡Èⲡ£¬Ä¿Ç°ÓÃÓÚSMAÏà¹Ø»ùÒò¼ì²âºÍ¿½±´ÊýÈ·¶¨µÄ·½·¨¸´ÔÓ¡¢ºÄʱ»òÎÞ·¨Í¬Ê±¼ì²â¶à¸ö°Ð±ê¡£±¾Ñо¿»ùÓÚÊý×ÖPCR¼¼Êõ½¨Á¢ÁËÄܹ»ÔÚµ¥¹ÜÍê³ÉSMN1ÍâÏÔ×Ó7ºÍ8ÓëSMN2ÍâÏÔ×Ó7ºÍ8¿½±´Êý¼ì²âµÄ·½·¨£¬¾ßÓÐ׼ȷ¡¢¿ìËÙ¡¢²Ù×÷¼òµ¥¡¢Ñù±¾ÓÃÁ¿ÉÙºÍÊÊÓÃÓÚ¶àÖÖÀàÐÍÑù±¾µÄÓÅÊÆ£¬ÎªSMAµÄ·Ö×ÓÕï¶Ï¡¢´ó¹æÄ£É¸²éºÍ¼²²¡ÑÏÖØ³Ì¶ÈÆÀ¹ÀÌṩÁËÒ»¸öÓÐÁ¦µÄ¹¤¾ß¡£

2.Ñо¿±³¾°
2021Äê12Ô£¬¹ú¼ÒÒ½±£¾Ö¹«²¼Ò»ÅúÐÂÒ©½øÒ½±££¬È«ÇòÊ׸öÓÃÓÚÖÎÁÆSMAµÄ¸ß¼ÛÒ©Î¡ªÅµÎ÷ÄÇÉúįעÉäÒºÃûÁÐÆäÖУ¬º±¼û²¡SMAÒ²Òò´ËÊܵ½´óÖÚ¹Ø×¢¡£SMAÊÇÒ»ÖÖÑÏÖØµÄÉñ¾¼¡Èâ¼²²¡£¬ÆäÌØÕ÷ÊǼ¹Ëèǰ½Ç¦Á-Ô˶¯Éñ¾ÔªµÄÍË»¯±äÐÔ£¬µ¼Ö½ü¶Ë¼¡ÈâÖð½¥ÎÞÁ¦¡¢Î®ËõºÍ̱»¾£¬·¢²¡ÂÊԼΪ1/10000£¬ÈËȺЯ´øÂÊԼΪ1/50£¬Êǵ¼ÖÂÐÂÉú¶ùËÀÍöµÄÖØÒªÒÅ´«ÒòËØÖ®Ò»¡£SMAÊÇÒ»ÖÖ³£È¾É«ÌåÒþÐÔÒÅ´«²¡£¬95%µÄ»¼ÕßÊÇÓÉÓÚSMN1»ùÒò7ºÅÍâÏÔ×Ó´¿ºÏȱʧ¶øÖ²¡£¨´ó²¿·ÖSMN1»ùÒò8ºÅÍâÏÔ×Ó¹²Í¬È±Ê§£©£»ÁíÒ»¸öÓëSMN1¸ß¶ÈͬԴµÄ»ùÒòSMN2Òѱ»Ö¤ÊµÓë¼²²¡ÑÏÖØ³Ì¶ÈÏà¹Ø£¬SMN2µÄ¿½±´ÊýÔÚÖÎÁÆÓëÓÃÒ©Öб»×÷ÎªÖØÒª²Î¿¼Êý¾Ý¡£Òò´Ë£¬¾«×¼µÄ¼ì²â³öSMN1ºÍSMN2µÄ¿½±´Êý¶ÔÓÚÁÙ´²¼²²¡Õï¶Ï¡¢Ð¯´øÕßɸ²é¡¢¼²²¡ÑÏÖØÐÔÔ¤²âÆÀ¹À¡¢ÖÎÁƺÍÔ¤ºóÖÁ¹ØÖØÒª¡£
3.·½·¨Óë½á¹û
±¾Ñо¿½¨Á¢ÁËÒ»ÖÖ»ùÓÚÊý×ÖPCRµ¥¹Ü¼ì²âSMN1ÍâÏÔ×Ó7ºÍ8¡¢SMN2ÍâÏÔ×Ó7ºÍ8¼°ÄڲλùÒòµÄ·½·¨£¬Í¨¹ýÊý×ÖPCR¼¼Êõ¾ø¶Ô¶¨Á¿Ä¿±ê»ùÒòºÍÄڲλùÒòµÄÄ£°å¿½±´Êý£¬¼ÆËãÄ¿±ê»ùÒòÓëÄڲλùÒòÄ£°å¿½±´ÊýµÄ±ÈÖµÀ´ÊµÏÖÄ¿±ê»ùÒò¿½±´ÊýµÄ¼ì²â£¨Í¼1£©¡£×÷ÕßÒÔ²»Í¬µÄÓ«¹âȾÁϱê¼Ç5¸ö»ùÒòµÄ̽Õ룬²¢ÅäºÏÐÂôàÉúÎïµÄ5ɫ΢ҺµÎÊý×ÖPCRϵͳ½øÐмì²â£¬ÊµÏÖÁË5¸ö»ùÒòµ¥¹Ü¼ì²â¡£´ËÍ⣬ΪÁËÄܹ»Çø·Ö¸ß¶ÈͬԴµÄSMN1ºÍSMN2»ùÒò£¨ÔÚÍâÏÔ×Ó7ºÍÍâÏÔ×Ó8Éϸ÷Ö»ÓÐ1¸ö¼î»ùµÄ²îÒ죩£¬×÷ÕßʹÓÃÁËС¹µ½áºÏÎMinor groove binder£¬MGB£©ºÍËøºËËᣨLocked nucleic acid£¬LNA£©¶Ô¼ì²â̽Õë½øÐÐÐÞÊΡ£

ͼ1»ùÓÚÊý×ÖPCRµÄSMA¼ì²âÁ÷³Ì
ΪÁËÑéÖ¤·½·¨µÄ׼ȷÐÔ£¬×÷ÕßÊÕ¼¯Á˹²317Àý²»Í¬ÀàÐ͵ÄÁÙ´²Ñù±¾½øÐмì²â£¬°üÀ¨ÍâÖÜѪ¡¢ÑòË®¡¢ÈÞë¡¢¿ÚÇ»ÊÃ×Ӻ͸ÉѪ°ß¡£ÔÚ317ÀýÑù±¾ÖУ¬¹²ÓÐ22Àý»¼Õß¡¢72ÀýЯ´øÕߺÍ223ÀýÕý³£ÈË£¨Í¼2£©£¬½á¹ûÏÔʾ¸Ã·½·¨¶ÔÓÚ²»Í¬ÀàÐ͵ÄÑù±¾¶¼Äܹ»ÊµÏÖÄ¿±ê»ùÒò¿½±´Êý׼ȷµÄ¼ì²â¡£´ËÍ⣬×÷ÕßÒ²¹Û²ìµ½ÁËSMN2»ùÒò¿½±´Êý¸ü¶àµÄSMA»¼Õß¾ßÓиüÇáµÄ±íÐÍ£»Í¨¹ý¶ÔÄ¿±ê»ùÒòµÄͬʱ¼ì²â£¬Òà¹Û²ìµ½»¼Õß¡¢Ð¯´øÕߺÍÕý³£ÈËȺÖж¼³öÏÖ»ùÒòת»»¶ø²úÉúÈںϻùÒòµÄÇé¿ö¡£

ͼ2²»Í¬ÀàÐ͵ÄÁÙ´²Ñù±¾µÄSMN1ºÍSMN2¼ì²â½á¹û·Ö²¼£¨TGR£ºTarget gene ratio,Ä¿±ê»ùÒòÓëÄڲλùÒòÄ£°å¿½±´ÊýµÄ±ÈÖµ£©
ÓëÏÖÓеļì²â·½·¨ÈçÏÞÖÆÐÔÆ¬¶Î³¤¶È¶à̬ÐÔ£¨Restriction fragment length polymorphism£¬RFLP£©ºÍÓ«¹â¶¨Á¿PCR£¨Quantitative PCR£¬qPCR£©Ïà±È£¬±¾·½·¨Äܾ«×¼¼ì²â¸ü¶à°Ð±ê£¬ÇÒ¶ÔÄ£°åÁ¿ÒªÇóµÍ£¨¡Ý 1.5 ng£©£»Óë½ð±ê×¼·½·¨¶àÖØÁ¬½Ó̽ÕëÀ©Ôö£¨Multiplex ligation-dependent probe amplification£¬MLPA£©Ïà±È£¬±¾·½·¨¼ì²âÖÜÆÚ¸ü¶Ì£¨Ê״γö½á¹û24 hvs2.5 h£©¡¢²Ù×÷¸ü¼òµ¥¡¢¶ÔÄ£°åÁ¿µÄÒªÇóµÍºÍÊÊÓÃÓÚ¸ü¶àÖÖÀàÐÍÑù±¾¡£
4.Ñо¿½áÂÛ
±¾¹¤×÷Ñз¢ÁË»ùÓÚÊý×ÖPCR¼¼ÊõµÄSMA¾«×¼¼ì²â·½·¨£¬Äܹ»ÔÚµ¥¹ÜÍê³ÉSMN1ÍâÏÔ×Ó7ºÍ8ÓëSMN2ÍâÏÔ×Ó7ºÍ8¿½±´ÊýµÄ¼ì²â£¬¾ßÓмì²â׼ȷ¡¢¼ì²â¿ìËÙ¡¢²Ù×÷¼òµ¥¡¢¼ì²âÏ޵ͺÍÊÊÓÃÓÚ¶àÖÖÀàÐÍÑù±¾µÄÓÅÊÆ£¬ÎªSMA·Ö×ÓÕï¶Ï¡¢´ó¹æÄ£É¸²éºÍ¼²²¡ÑÏÖØ³Ì¶ÈÆÀ¹ÀÌṩÁËÒ»¸öÓÐÁ¦µÄ¹¤¾ß¡£
5.×÷Õß½éÉÜ
Ç廪´óѧ³ÂÜ·ÈçÓëÊ×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©¸¾²úÒ½ÔºãÆÓÐʥΪ¸ÃÑо¿µÄ¹²Í¬µÚÒ»×÷Õߣ¬Ç廪´óѧ¹ùÓÀÓë±±¾©´óѧµÚÒ»Ò½ÔºÂíµtéªÎª¸ÃÑо¿µÄ¹²Í¬Í¨Ñ¶×÷Õß¡£¸ÃÑо¿µÃµ½Á˿Ƽ¼²¿¹ú¼ÒÖØµãÑз¢¼Æ»®¡¢Ç廪´óѧ´º·ç»ù½ðºÍ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίÇàÄê¿ÆÑ§»ù½ðµÄÁªºÏ×ÊÖú¡£
ÔÎÄÁ´½Ó£ºhttps://doi.org/10.1021/acs.analchem.1c04403